Velan Capital Investment Management as of Dec. 31, 2021
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 27 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Jasper Therapeutics | 17.8 | $23M | 3.2M | 7.13 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 13.9 | $18M | 622k | 28.89 | |
| Science 37 Holdings | 11.6 | $15M | 1.2M | 12.47 | |
| Immunocore Hldgs Ads (IMCR) | 7.8 | $10M | 293k | 34.24 | |
| Intra Cellular Therapies Call Option (ITCI) | 6.1 | $7.9M | 150k | 52.34 | |
| Adma Biologics (ADMA) | 5.9 | $7.6M | 5.4M | 1.41 | |
| Oncology Institu (TOI) | 4.5 | $5.9M | 600k | 9.75 | |
| 9 Meters Biopharma | 3.3 | $4.2M | 4.3M | 0.98 | |
| Nyxoah S A SHS (NYXH) | 3.2 | $4.1M | 178k | 23.00 | |
| Rapt Therapeutics (RAPT) | 3.1 | $4.0M | 110k | 36.73 | |
| Tela Bio (TELA) | 3.0 | $3.8M | 300k | 12.80 | |
| Caribou Biosciences (CRBU) | 2.5 | $3.2M | 211k | 15.09 | |
| Conformis | 2.5 | $3.2M | 4.2M | 0.76 | |
| Somalogic Class A Com | 2.1 | $2.7M | 235k | 11.64 | |
| Chimerix (CMRX) | 2.0 | $2.6M | 400k | 6.43 | |
| Capital Sr Living Corp (SNDA) | 1.8 | $2.4M | 83k | 28.49 | |
| Healthcare Services (HCSG) | 1.7 | $2.2M | 123k | 17.79 | |
| Mei Pharma Com New | 1.5 | $2.0M | 748k | 2.67 | |
| Radius Health Com New | 1.5 | $1.9M | 275k | 6.92 | |
| Rezolute Com New (RZLT) | 1.1 | $1.4M | 300k | 4.78 | |
| Xeris Pharmaceuticals Call Option (XERS) | 1.0 | $1.3M | 447k | 2.93 | |
| Curis Com New | 0.9 | $1.2M | 250k | 4.76 | |
| Graf Acquisition Corp Iv | 0.6 | $836k | 87k | 9.66 | |
| Envveno Medical (NVNO) | 0.4 | $491k | 75k | 6.59 | |
| Graf Acquisition Corp Iv *w Exp 05/31/202 | 0.0 | $23k | 20k | 1.15 | |
| Bridgebio Pharma (BBIO) | 0.0 | $19k | 1.1k | 16.89 | |
| Somalogic *w Exp 08/31/202 | 0.0 | $7.0k | 2.1k | 3.40 |
